AI assistant
Sending…
Evogene Ltd. — Board/Management Information 2023
Dec 19, 2023
6785_rns_2023-12-19_c4b31b7b-0ddc-4ca3-b4c9-35062fc868c5.htm
Board/Management Information
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation false
| ����� ��"� | 2 380 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 13041 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 19/12/2023 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2023-02-137829 | Time of broadcast: 13:27 13:27 |
The corporation scheduled the publication of the report to 19/12/2023 14:00Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onCasterra Appoints New CEO and Expands Team to Drive Growth and Innovation
a2330669_accessible_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 05/12/2023 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: | |
| Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
More from Evogene Ltd.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Apr 10
Director's Dealing
2026
Apr 10
Regulatory Filings
2026
Apr 3
Report Publication Announcement
2026
Apr 3
Report Publication Announcement
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 26
Report Publication Announcement
2026
Mar 26